Global and United States Cancer mTOR Inhibitors Market Research by Company, Type & Application 2013-2025

1 Market Overview

1.1 Market Segment Overview

1.1.1 Product Definition

1.1.2 Market by Type

1.1.2.1 Afinitor/Votubia

1.1.2.2 Afinitor Disperz andndash; mTOR inhibitor for Rare Pediatric Brain Tumor

1.1.2.3 Torisel (Temsirolimus)

1.1.2.4 Evertor andndash

1.1.3 Market by Application

1.1.3.1 Breast Cancer

1.1.3.2 Hematological Malignancy

1.1.3.3 Neuroendocrine Tumors

1.1.3.4 Hepatocellular Carcinoma

1.1.3.5 Glioblastoma

1.2 Global and Regional Market Size

1.2.1 Global Overview

1.2.2 United States Overview

2 Global and Regional Market by Company

2.1 Global

2.1.1 Global Sales by Company

2.1.2 Global Price by Company

2.2 United States

2.2.1 United States Sales by Company

2.2.2 United States Price by Company

3 Global and Regional Market by Type

3.1 Global

3.1.1 Global Sales by Type

3.1.2 Global Price by Type

3.2 United States

3.2.1 United States Sales by Type

3.2.2 United States Price by Type

4 Global and Regional Market by Application

4.1 Global

4.1.1 Global Sales by Application

4.1.2 Global Price by Application

4.2 United States

4.2.1 United States Sales by Application

4.2.2 United States Price by Application

5 Regional Trade

5.1 Export

5.2 Import

6 Key Manufacturers

6.1 Abraxis BioScience

6.1.2 Company Information

6.1.2 Product Specifications

6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

6.2 Adimab

6.2.1 Company Information

6.2.2 Product Specifications

6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

6.3 Celgene Corporation

6.3.1 Company Information

6.3.2 Product Specifications

6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

6.4 Celator Pharmaceuticals

6.4.1 Company Information

6.4.2 Product Specifications

6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

6.5 Eli Lilly

6.5.1 Company Information

6.5.2 Product Specifications

6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

6.6 Exelixis

6.6.1 Company Information

6.6.2 Product Specifications

6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

6.7 GlaxoSmithKline

6.7.1 Company Information

6.7.2 Product Specifications

6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

6.8 HEC Pharm

6.8.1 Company Information

6.8.2 Product Specifications

6.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

6.9 Intellikine

6.9.1 Company Information

6.9.2 Product Specifications

6.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

6.10 Novartis

6.10.1 Company Information

6.10.2 Product Specifications

6.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

6.11 Oneness Biotech

6.12 PIQUR Therapeutics

6.13 Semafore Pharmaceuticals

6.14 Takeda

6.15 Wyeth

7 Industry Upstream

7.1 Industry Chain

7.2 Raw Materials

8 Market Environment

8.1 SWOT

8.2 Porter's Five Forces

9 Conclusion

Table Global Market Sales Revenue Share by Company 2013-2017

Table Global Market Sales Volume by Company 2013-2017

Table Global Market Sales Volume Share by Company 2013-2017

Table Global Price by Company 2013-2017

Table United States Market Sales Revenue by Company 2013-2017

Table United States Market Sales Revenue Share by Company 2013-2017

Table United States Market Sales Volume by Company 2013-2017

Table United States Market Sales Volume Share by Company 2013-2017

Table United States Price by Company 2013-2017

Table Global Market Sales Revenue by Type 2013-2017

Table Global Market Sales Revenue Share by Type 2013-2017

Table Global Market Sales Volume by Type 2013-2017

Table Global Market Sales Volume Share by Type 2013-2017

Table Global Price by Type 2013-2017

Table United States Market Sales Revenue by Type 2013-2017

Table United States Market Sales Revenue Share by Type 2013-2017

Table United States Market Sales Volume by Type 2013-2017

Table United States Market Sales Volume Share by Type 2013-2017

Table United States Price by Type 2013-2017

Table Global Market Sales Revenue by Application 2013-2017

Table Global Market Sales Revenue Share by Application 2013-2017

Table Global Market Sales Volume by Application 2013-2017

Table Global Market Sales Volume Share by Application 2013-2017

Table Global Price by Application 2013-2017

Table United States Market Sales Revenue by Application 2013-2017

Table United States Market Sales Revenue Share by Application 2013-2017

Table United States Market Sales Volume by Application 2013-2017

Table United States Market Sales Volume Share by Application 2013-2017

Table United States Price by Application 2013-2017

Table United States Export 2013-2017 (Million USD)

Table United States Export 2013-2017 (Volume)

Table United States Import 2013-2017 (Million USD)

Table United States Import 2013-2017 (Volume)

Table Sales Revenue, Volume, Price, Cost and Margin of Abraxis BioScience

Table Sales Revenue, Volume, Price, Cost and Margin of Adimab

Table Sales Revenue, Volume, Price, Cost and Margin of Celgene Corporation

Table Sales Revenue, Volume, Price, Cost and Margin of Celator Pharmaceuticals

Table Sales Revenue, Volume, Price, Cost and Margin of Eli Lilly

Table Sales Revenue, Volume, Price, Cost and Margin of Exelixis

Table Sales Revenue, Volume, Price, Cost and Margin of GlaxoSmithKline

Table Sales Revenue, Volume, Price, Cost and Margin of HEC Pharm

Table Sales Revenue, Volume, Price, Cost and Margin of Intellikine

Table Sales Revenue, Volume, Price, Cost and Margin of Novartis

Table Sales Revenue, Volume, Price, Cost and Margin of Oneness Biotech

Table Sales Revenue, Volume, Price, Cost and Margin of PIQUR Therapeutics

Table Sales Revenue, Volume, Price, Cost and Margin of Semafore Pharmaceuticals

Table Sales Revenue, Volume, Price, Cost and Margin of Takeda

Table Sales Revenue, Volume, Price, Cost and Margin of Wyeth